Search
OmniAb Inc
OABIAdd to Watchlist
4.470USD
+0.030+0.68%
Close 09-18 16:00（ET）
649.17MMarket Cap
LossP/E TTM
OmniAb Inc (OABI) Stock Price Target & Forecast
Analyst Rating
Based on 7 analysts giving stock ratings to OmniAb Inc in the past month.
Buy
2 Strong Buy
5 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
7.667USD+72.67%
OABI Analyst Recommendation Trends
In the current month, OABI has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. OABI average Analyst price target in the last month is 7.667.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
2
2
2
2
2
2
2
2
5
5
5
5
5
5
5
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
7
7
7
7
7
7
7
OABI Analyst Rating for Peer Comparison
Updated: Sep 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Ascendis Pharma A/S
ASND
10
10
0
0
0
20
Financial Forecasting
Based on analysts' estimates, OABI EPS is projected to reach -0.122 in FY2026Q3, following reported EPS of -0.045 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.09
-0.10
-0.12
-0.12
-0.13
Actual
-0.11
-0.06
-0.05
--
--
Surprise
-25.12%
+39.90%
+62.09%
--
--
FAQs
What is OmniAb Inc's expected revenue for the next quarter?
OmniAb Inc's expected revenue is 3.43M.
What is OmniAb Inc's price target?
Analysts forecast that OmniAb Inc's price target is USD 7.67, with the highest forecast at USD 11.00 and the lowest forecast at USD 4.00.
How have OmniAb IncOABI's recent earnings per share performed?
The market expectation was USD -0.05, while OmniAb IncOABI's earnings per share (EPS) for the previous quarter was USD -0.06. EPS for the next quarter is expected at USD -0.12.
What is the analyst rating for OmniAb Inc?
Based on the ratings of OmniAb Inc's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.